Tryptophan metabolites: a scent signature for cancer's immunosuppressive status?
Zhang
Wei
W
Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. wzhang@mdanderson.org
D000818:Animals; D015415:Biomarkers; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D006801:Humans; D007157:Immunologic Surveillance / Q000502:physiology*; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000502:physiology*; D007376:Interleukin-2 / Q000502:physiology; D009363:Neoplasm Proteins / Q000502:physiology*; D009369:Neoplasms / Q000276:immunology* / Q000378:metabolism; D051567:Proto-Oncogene Proteins c-vav / Q000502:physiology; D015398:Signal Transduction; D014364:Tryptophan / Q000378:metabolism*; D019139:Tumor Escape / Q000502:physiology*
D015415:Biomarkers; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D007376:Interleukin-2; D009363:Neoplasm Proteins; D051567:Proto-Oncogene Proteins c-vav; C496618:VAV1 protein, human; D014364:Tryptophan